Assessment for Risk of Bias in Systematic Reviews and Meta-Analyses in the Field of Hepatology

por Kim, Gaeun, Cho, Youn Zoo, Baik, Soon Koo
Publicado 2015

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review

por Kim, Gaeun, Cho, Youn Zoo, Baik, Soon Koo, Kim, Moon Young, Hong, Won Ki, Kwon, Sang Ok
Publicado 2015

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model

por Jang, Yoon Ok, Kim, Moon Young, Cho, Mee Yon, Baik, Soon Koo, Cho, Youn Zoo, Kwon, Sang Ok
Publicado 2014

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis

por Lim, Yoo Li, Choi, Eunhee, Jang, Yoon Ok, Cho, Youn Zoo, Kang, Yong Seok, Baik, Soon Koo, Kwon, Sang Ok, Kim, Moon Young
Publicado 2016

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients

por Yoon, Hye-Jin, Cho, Youn-Zoo, Kim, Ji-young, Kim, Byung-Joon, Park, Keun-Young, Koh, Gwan-Pyo, Lee, Dae-Ho, Lim, Dong-Mee
Publicado 2012

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

por Cho, Youn Zoo, Park, So Yeon, Choi, Eun Hee, Baik, Soon Koo, Kwon, Sang Ok, Kim, Young Ju, Cha, Seung Hwan, Kim, Moon Young
Publicado 2015

Incremental Predictive Value of Serum AST-to-ALT Ratio for Incident Metabolic Syndrome: The ARIRANG Study

por Yadav, Dhananjay, Choi, Eunhee, Ahn, Song Vogue, Baik, Soon Koo, Cho, Youn zoo, Koh, Sang Baek, Huh, Ji Hye, Chang, Yoosoo, Sung, Ki-Chul, Kim, Jang Young
Publicado 2016

Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients

por Kim, Sung-Tae, Kim, Byung-Joon, Lim, Dong-Mee, Song, In-Geol, Jung, Jang-Han, Lee, Kang-Woo, Park, Keun-Young, Cho, Youn-Zoo, Lee, Dae-Ho, Koh, Gwan-Pyo
Publicado 2011

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)

por Kim, Sung-Tae, Kim, Byung-Joon, Lim, Dong-Mee, Song, In-Geol, Jung, Jang-Han, Lee, Kang-Woo, Park, Keun-Young, Cho, Youn-Zoo, Lee, Dae-Ho, Koh, Gwan-Pyo
Publicado 2011

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

por Kim, Jae Hyun, Kim, Jung Min, Cho, Youn Zoo, Na, Ji Hoon, Kim, Hyun Sik, Kim, Hyoun A, Kang, Hye Won, Baik, Soon Koo, Kwon, Sang Ok, Cha, Seung Hwan, Kim, Young Ju, Kim, Moon Young
Publicado 2014

Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease

por Hong, Won Ki, Shim, Kwang Yong, Baik, Soon Koo, Kim, Moon Young, Cho, Mee Yon, Jang, Yoon Ok, Park, Young Shik, Han, Jin, Kim, Gaeun, Cho, Youn Zoo, Hwang, Hye Won, Lee, Jin Hyung, Chae, Myeong Hun, Kwon, Sang Ok
Publicado 2014

The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data

por Hong, Won Ki, Kim, Moon Young, Baik, Soon Koo, Shin, Seung Yong, Kim, Jung Min, Kang, Yong Seok, Lim, Yoo Li, Kim, Young Ju, Cho, Youn Zoo, Hwang, Hye Won, Lee, Jin Hyung, Chae, Myeong Hun, Kim, Hyoun A, Kang, Hye Won, Kwon, Sang Ok
Publicado 2013